GRAIL, Inc. (GRAL)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$80.34-0.35%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · GRAL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenues | 165.3 | 147.2 | 125.6 | 93.1 |
| Operating Expenses & Income | ||||
| R&D Expenses | 191.0 | 195.8 | 322.4 | 338.7 |
| Operating Income | (559.3) | (562.2) | (2,189.2) | (1,515.4) |
| Earnings from Continuing Operations | ||||
| Interest & Investment Income | 29.3 | 28.7 | 26.7 | 8.0 |
| Other Non-Operating Income / Expenses | 29.8 | 27.7 | 26.8 | 7.7 |
| EBT, Incl. Unusual Items | (529.5) | (534.5) | (2,162.4) | (1,507.6) |
| Income Tax Expense | (137.9) | (126.2) | (135.4) | (42.0) |
| Net Income | ||||
| Net Income | (391.6) | (408.4) | (2,027.0) | (1,465.7) |
| Per Share | ||||
| Basic EPS | (9.08) | (11.11) | (63.54) | (47.21) |
| Diluted EPS | (9.08) | (11.11) | (63.54) | (47.21) |
| Revenue per Share | 3.83 | — | — | — |
| Basic Weighted Avg Shares | 43.1 | 36.8 | 31.9 | 31.0 |
| Diluted Weighted Avg Shares | 43.1 | 36.8 | 31.9 | 31.0 |
| Supplemental | ||||
| EBIT | (559.3) | (562.2) | (2,189.2) | (1,515.4) |
| Effective Tax Rate | 26.0% | — | — | 2.8% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.